Landec Corp. (NASDAQ:LNDC) shares rose 3.4% during mid-day trading on Friday . The stock traded as high as $11.00 and last traded at $10.99, with a volume of 51,160 shares traded. The stock had previously closed at $10.63.

LNDC has been the topic of a number of research reports. Zacks Investment Research downgraded shares of Landec Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday, May 31st. Maxim Group initiated coverage on shares of Landec Corp. in a research report on Tuesday, June 7th. They set a “buy” rating and a $16.00 target price on the stock. Finally, Wedbush initiated coverage on shares of Landec Corp. in a research report on Thursday, July 7th. They set a “neutral” rating and a $12.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $15.10.

The company’s market capitalization is $302.13 million. The company’s 50 day moving average price is $11.01 and its 200 day moving average price is $11.03.

An institutional investor recently raised its position in Landec Corp. stock. Heartland Advisors Inc. increased its position in Landec Corp. (NASDAQ:LNDC) by 5.9% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 936,452 shares of the company’s stock after buying an additional 52,509 shares during the period. Heartland Advisors Inc. owned 3.46% of Landec Corp. worth $11,078,000 at the end of the most recent reporting period.

Landec Corporation designs, develops, manufactures and sells differentiated products for food and biomaterials markets and licenses technology applications to partners. The Company’s segments include Food Products Technology, Food Export and Hyaluronan-based Biomaterials. The Company’s Food Products Technology segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.